Abstract
The rational design of cancer chemotherapeutic agents must ultimately be based on an exploitable biochemical difference between normal host cells and the invading cancer cells. Although much is known about the biologic activity of certain agents, such as 6-mercaptopurine and 6-thioguanine, the basis of their selective action on cancer cells is still not fully understood. This selectivity could result from greater catabolism of the drug by normal cells, since it is known that the xanthine oxidase level of cancer cells is generally lower than that of normal cells (Bergel et al., 1957). The metabolic state of treated cells must also be important, since established solid tumors with a low growth fraction do not normally respond well to antimetabolites, purines or otherwise (Laster et al., 1969). Because of our limited knowledge about the basis of selective toxicity of purine antagonists, we must base the design of new agents on what is known about the metabolism and the mechanisms of action of purine analogs and the effects of structural changes on both of these. Although some of these topics will be discussed in more detail later in this volume, our knowledge of the biologically active purine analogs will be summarized briefly here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Acton, E.M., Goodman, L., Iwamoto, R.H.: 2′-Deoxythioguanosine and related nucleosides. J. med. Chem. 6, 684–688 (1963).
Aoton, E.M., Ryan, K.J., Henry, D.W., Goodman, L.: Synthesis of the nucleoside antibiotic formycin B. Chem. Commun. 986–988 (1971).
Allan, P.W., Bennett, L.L., Jr.: Metabolism of 8-azainosine. Proc. Amer. Assoc. Cancer Res. 11, 2 (1970).
Allan, P.W., Bennett, L.L., Jr.: 6-Methylthioguanylic acid, a metabolite of 6-thioguanine. Biochem. Pharmacol. 20, 847–852 (1971).
Allan, P.W., Schnebli, H.P., Bennett, L.L., Jr.: Conversion of 6-mercaptopurine and 6-mercaptopurine ribonucleoside to 6-methylmercaptopurine ribonucleotide in human epidermoid carcinoma No. 2 cells in culture. Biochim. biophys. Acta (Amst.) 114, 647–650 (1966).
Ammann, C.A., Safferman, R.S.: The onion test as a possible screening method for antitumor agents. Antibiot. Chemother. 8, 1 (1958).
Anzai, K., Nakamura, G., Suzuki, S.: A new antibiotic, tubercidin. J. Antibiot. (Tokyo) 10, 201–204 (1957).
Baker, B.R.: Stereochemistry of nucleoside synthesis. In: Ciba foundation symposium on chemistry and biology of purines. London: J. and A. Churchill, Ltd. 1957.
Baker, B.R., Hewson, K.: Synthesis of potential anticancer agents. VIII. Nucleosides derived from L-rhamnofuranose. J. org. Chem. 22, 966–971 (1957).
Baker, B.R., Schaub, R.E., Kissman, H.M.: Puromycin. Synthetic studies. XV. 3′-Amino-3′-deoxyadenosine. J. Amer. chem. Soc. 77, 5911–5915 (1955a).
Baker, B.R., Schaub, R.E., Williams, J.H.: Puromycin. Synthetic studies. VIII. Synthesis of 3-amino-3-deoxy-D-ribofuranoside derivative. A second synthesis of 3-amino-3-deoxy-D-ribose. J. Amer. chem. Soc. 77, 7–12 (1955b).
Baker, B.R., Schaub, R.E., Joseph, J.P., Williams, J.H.: Puromycin. Synthetic studies. IX. Total synthesis. J. Amer. chem. Soc. 77, 12–15 (1955c).
Baker, B.R., Hewson, K., Thomas, H.J., Johnson, J.A., Jr.: Synthesis of potential anticancer agents. VI. Use of O-benzoyl blocking group for synthesis of 6-chloropurine nucleosides. J. org. Chem. 22, 954–959 (1957).
Balsiger, R.W., Fikes, A.L., Johnston, T.P., Montgomery, J.A.: (2-Chloroethyl)thiopurines and the corresponding dihydrothiazolopurines. J. org. Chem. 26, 3446–3451 (1961).
Beaman, A.G., Robins, R.K.: Potential purine antagonists. XXVII. Synthesis and reactions of some purinesulfonyl fluorides. J. Amer. chem. Soc. 83, 4038–4044 (1961).
Beaman, A.G., Robins, R.K.: Potential purine antagonists. XXXIII. Synthesis of chloropurines. J. appl. Chem. 12, 432–437 (1962).
Beaman, A.G., Gusta, J.F., Robins, R.K.: Potential purine antagonists. XXVIII. The preparation of various bromopurines. J. org. Chem. 27, 986–990 (1962).
Bell, J.P., Faures, M.L., LePage, G.A., Kimball, A.P.: Immunosuppressive and antitumor activity of the periodate oxidation product of β-D-ribosyl-6-methylthiopurine. Cancer Res. 28, 782–787 (1968).
Bendich, A., Russell, P.J., Jr., Fox, J.J.: The synthesis and properties of 6-chloropurine and purine. J. Amer. chem. Soc. 76, 6073–6077 (1954).
Bendich, A., Tinker, J.F., Brown, G.B.: A synthesis of isoguanine labeled with isotopic nitrogen. J. Amer. chem. Soc. 70, 3109–3113 (1948).
Bennett, L.L., Jr., Montgomery, J. A.: Design of anticancer agents, problems and approaches. In: Methods in cancer research, vol. 3. New York: Academic Press 1967.
Bennett, L.L., Jr., Smithers, D.: Feedback inhibition of purine biosynthesis in H.Ep. No. 2 cells by adenine analogs. Biochem. Pharmacol. 13, 1331–1339 (1964).
Bennett, L.L., Jr., Vail, M.H., Chumley, S., Montgomery, J.A.: Activity of adenosine analogs against a cell culture line resistant to 2-fluoroadenine. Biochem. Pharmacol. 15, 1719–1728 (1966a).
Bennett, L.L., Jr., Schnebli, H.P., Vail, M.H., Allan, P.W., Montgomery, J.A.: Purine ribonucleoside kinase activity and resistance to some analogs of adenosine. Molec. Pharmacol. 2, 432–443 (1966b).
Bennett, L.L., Jr., Brockman, R.W., Schnebli, H.P., Chumley, S., Dixon, G.J., Schabel, F.M., Jr., Dulmadge, E.A., Skipper, H.E., Montgomery, J.A., Thomas, H. J.: Activity and mechanism of action of 6-methylthiopurine ribonucleoside in cancer cells resistant to 6-mercaptopurine. Nature (Lond.) 205, 1276–1279 (1965).
Bentley, H.R., Cunningham, K.G., Spring, F.S.: Cordycepin, a metabolic product from cultures of Cordyceps militaris (Linn.) link. Part II. The structure of cordycepin. J. chem. Soc, 2301–2305 (1951).
Bergel, F., Bray, R.C., Haddow, A., Lewin, I.: Enzyme control of purines by xanthine oxidase. In: Ciba foundation symposium on chemistry and biology of purines. London: J. and A. Churchill, Ltd. 1957.
Bergmann, W., Stempien, M.F.: Contributions to the study of marine products. XLIII. The nucleosides of sponges. V. The synthesis of spongosine. J. org. Chem. 22, 1575–1577 (1957).
Birkoper, L., Ritter, A., Kuhlthau, H.P.: Harnsäure-3-ribofuranosid und harnsäure-3-glucopyranosid. Angew. Chem. 75, 209–210 (1963).
Bloch, A., Nichol, C.A.: Inhibition of ribosephosphate pyrophosphokinase activity by decoyinine, an adenine nucleoside. Biochem. biophys. Res. Commun. 16, 400–403 (1964).
Bloch, A., Mthtch, E., Leonard, R. J., Nichol, C.A.: Studies on the biologic activity and mode of action of 7-deazainosine. Cancer Res. 29, 110–115 (1969).
Bobek, M., Farkaš, J., Šorm, F.: Synthesis of 3-(β-D-ribofuranosyl)-5, 7-dihydroxy-1 H- pyrazolo[4, 3-d]pyrimidine. Tetrahedron Let., 4611–4614 (1970a).
Bobek, M., Whistler, R.L., Bloch, A.: Preparation and activity of the 4′-thio derivatives of some 6-substituted purine nucleosides. J. med. Chem. 13, 411–413 (1970b).
Bowles, W.A., Schneider, F.H., Lewis, L.R., Robins, R.K.: Synthesis and antitumor activity of 9-(tetrahydro-2-furyl) purine analogs of biologically important deoxynucleosides. J. med. Chem. 6, 471–480 (1963).
Bray, R.C.: Xanthine oxidase. In: The enzymes, 2nd ed., vol. 7, New York and London: Academic Press 1963.
Bredereck, H., Ulmer, H., Waldmann, H.: Purin aus Formamid. Methylierung und Bromierung des Purins (Synthesenin der Purinreihe VII. Mitteil). Chem. Ber. 89, 12–18 (1956).
Bredereck, H., Effenberger, F., Rainer, G., Schosser, H.P.: Saureamid-reactionen, XXXI. Eine einfache Synthese des Purins. Ann. Chem. Liebigs. 659, 133–138 (1962).
Brink, J.J., Le Page, G.A.: Metabolism and distribution of 9-β-D-arabinofuranosyladenine in mouse tissues. Cancer Res. 24, 1042–1049 (1964).
Brockman, R. W.: Mechanism of resistance to anticancer agents. Adv. Cancer Res. 7, 129–234 (1963).
Brockman, R.W., Anderson, E.P.: Biochemistry of cancer (metabolic aspects). Ann. Rev. Biochem. 32, 463–512 (1963).
Brockman, R.W., Chumley, S.: Inhibition of formylglycinamide ribonucleotide synthesis in neoplastic cells by purines and analogs. Biochim. biophys. Acta (Amst.) 95, 365–379 (1965).
Brown, D.J.: The pyrimidines: The chemistry of heterocyclic compounds. (A. Weissberger, Ed.) New York: Wiley and Sons 1962.
Brown, G.B., Weliky, V.S.: The synthesis of 9-β-D-ribofuranosylpurine and the identity of nebularine. J. biol. Chem. 204, 1019–1024 (1953).
Brown, G.B., Weliky, V.S..: 2-Chloroadenine and 2-chloroadenosine. J. org. Chem. 23, 125–126 (1958).
Brown, G.B., Levin, G., Murphy, S., Sele, A., Reilly, H.C., Tarnowski, G.S., Schmid, F. A., Teller, M.N., Stock, C.C.: Purine N-oxides. XV. The synthesis of 6-mercaptopurine 3-N-oxide. Its chemotherapeutic possibilities. J. med. Chem. 8, 190–195 (1965).
Caldwell, I.C., Henderson, J.F., Paterson, A.R.P.: The metabolism of formycin, an adenosine analog. Can. J. Chem. 47, 901–908 (1969).
Caskey, C.T., Ashton, D.M., Wyngaarden, J.B.: The enzymology of feedback inhibition of glutamine phosphoribosylpyrophosphate amidotransferase by purine ribonucleotides. J. biol. Chem. 239, 2570–2579 (1964).
Černý, A., Semonský, M.: Contribution to the synthesis of 6-mercaptopurine. Cs. Farm. 7, 402–403 (1958).
Černý, A., Semonský, M.: Substances with antineoplastic activity XVII. Preparation of 6-(4-carboxybutyl)thiopurine. Arzneim.-Forsch. 17, 1034–1036 (1967).
Černý, A., Semonský, M., Jelínek, V.: Substances with antineoplastic activity. III. Some derivatives and analogs of 6-(l-carboxy-4-butyl)thiopurine. Coll. Czech. Chem. Comm. 27, 57–63(1962).
Černý, A., Kotva, R., Vesela, H., Jelinek, V., Semonský, M.: Substances with antineoplastic activity. XXIII. Synthesis of 6-(4-carboxybutyl)thionebularin and its effect on some transplantable animal tumors. Coll. Czech. Chem. Comm. 33, 1474–1479 (1968).
Černý, A., Kotva, R., Francova, V., Franc, Z., Raz, K., Semonsky, M.: Substances with antineoplastic activity. XIV. Some nuclear hydroxylated 6-(4-carboxybutyl)- and 6-(2-carboxyethyl)thiopurines. Coll. Czech. Chem. Comm. 31, 1824–1830 (1966).
Černý, A., Semonsky, M., Jelinek, V., Francova, V., Raz, K., Franc, Z.: Substances with antineoplastic activity. XV. Some esters of 6-(4-carboxybutyl)thiopurine. Coll. Czech. Chem. Comm. 32, 1035–1044 (1967).
Chang, P. K.: Synthesis of some hydroxylamine derivatives of pyrimidines and purines. J. med. Chem. 8, 884 (1965).
Chang, P., Lythgoe, B.: Experiments on the synthesis of purine nucleosides. Part XXVII. l:2:3:5-Tetra-acetyl-D-oxyiofuranose and the D-xylofuranosides of theophylline and adenine. J. chem. Soc. 1992–1993 (1950).
Cheng, C.C., Robins, R.K.: Potential purine antagonists. VI. Synthesis of 1-alkyl- and l-aryl-4-substituted pyrazolo [3, 4-d]pyrimidines. J. org. Chem. 21, 1240–1256 (1956).
Chu, S.H.: Potential antitumor agents. Selenoguanosine and related compounds. J. med. Chem. 14, 254–255 (1971).
Chu, S., Harris, I. S., Mautner, H.G.: Synthesis of some 8-purinyl nitrogen mustards. J. org. Chem. 25, 1759–1761 (1960).
Coddington, A.: The preparation of 6-iV-methyldeoxyadenosine. Biochim. biophys. Acta (Amst.) 59, 472–474 (1962).
Cory, J.G., Suhadolnik, R.J.: Dechloronase activity of adenosine deaminase. Biochemistry 4, 1733–1734 (1965).
Cunningham, K.G., Hutchinson, S.A., Manson, W., Spring, F.S.: Cordycepin, a metabolic product from cultures of Cordyceps militaria (Linn) link. Part I. Isolation and characterization. J. chem. Soc. 2299–2300 (1951).
Currie, R., Bergel, F., Bray, R.C.: Enzymes and cancer, preparation and some properties of guanase from rabbit liver. Biochem. J. 104, 634–638 (1967).
Daves, G.D., Jr., Noell, C.W., Robins, R.K., Koppel, H.C., Beaman, A.G.: Potential purine antagonists. XXII. The preparation and reactions of certain derivatives of 2-amino-6-purinethiol. J. Amer. chem. Soc. 82, 2633–2640 (1960).
Davidson, J. D.: Studies on the mechanism of action of 6-mercaptopurine in sensitive and resistant L1210 leukemia in vitro. Cancer Res. 20, 225–232 (1960).
Davoll, J.: The synthesis of the v-triazolo[d] pyrimidine analogues of adenosine, inosine, guanosine, and xanthosine, and a new synthesis of guanosine. J. chem. Soc. 1593–1599 (1958).
Davoll, J.: Pyrcolo[2, 3-d]pyrimidines. J. chem. Soc. 131–138 (1960).
Davoll, J., Kerridge, K.A.: The preparation of some 1- and 2-β-D-ribofuranosylpyrazolo- [3, 4-d] pyrimidines. J. chem. Soc. 2589–2591 (1961).
Davoll, J., Lowy, B.A.: A new synthesis of purine nucleosides. The synthesis of adenosine, guanosine, and 2, 6-diamino-9-β-D-ribofuranosylpurine. J. Amer. chem. Soc. 73, 1650–1655 (1951).
Davoll, J., Lowy, B.A.: Some synthetic analogs of the natural purine nucleosides. J. Amer. chem. Soc. 74, 1563–1566 (1952).
Dickinson, M. J., Holly, F.W., Walton, E., Zimmerman, M.: 3′-Deoxynucleosides. V. 3′-Deoxy-2-fluoroadenosine. J. med. Chem. 10, 1165–1166 (1967).
Doerr, I.L., Wempen, L., Clarke, D.A., Fox, J.J.: Thiation of nucleosides. III. Oxidation of 6-mercaptopurines. J. org. Chem. 26, 3401–3409 (1961).
Duggan, D.E., Titus, E.: 6-Chloropurine and 6-chlorouric acid as substrates and inhibitors of purine-oxidizing enzymes. J. biol. Chem. 234, 2100–2104 (1959).
Dvonch, W., Fletcher, H., III., Gregory, F.J., Healy, E.-M., Warren, G.H., Albttrn, H. E.: Antitumor activity of periodate oxidation products of carbohydrates and their derivatives. Cancer Res. 26, 2386–2389 (1966).
Eaton, C.N., Denny, G.H., Jr.: Convenient synthesis of 2-fluoroadenine. J. org. Chem. 34, 747–748 (1969).
Elderfield, R.C., Prasad, R.N., Liao, T.-K.: Synthesis of potential anticancer compounds. XIV. Methanesulfonic acid ester analogs of nitrogen mustards. J. org. Chem. 27, 573–575 (1962).
Elion, G.B.: Condensed pyrimidine systems. XXII. N-methylpurines. J. org. Chem. 27, 2478–2491 (1962).
Elion, G.B.: Biochemistry and pharmacology of purine analogues. Fed. Proc. 26, 898–904 (1967).
Elion, G.B., Hitchings, G.H.: The synthesis of 6-thioguanine. J. Amer. chem. Soc. 77, 1676 (1955).
Elion, G.B., Retchings, G.H.: Studies on condensed pyrimidine systems. XVII. Some halo- genopurines. J. Amer. chem. Soc. 78, 3508–3510 (1956).
Elion, G.B., Hitchings, G.H.: Metabolic basis for the actions of analogs of purines and pyrimidines. Advanc. Chemother. 2, 91–177 (1967).
Elion, G.B., Burgi, E., Hitchings, G.H.: Studies on condensed pyrimidine systems. IX. The synthesis of some 6-substituted purines. J. Amer. chem. Soc. 74, 411–414 (1952).
Elion, G.B., Lange, W.H., Hitchings, G.H.: Studies on condensed pyrimidine systems. XVI. Purines and thiazolo [5, 4-d] pyrimidines from 4-amino-5-formamido-6-mercapto-pyrimidines. J. Amer. chem. Soc. 78, 2858–2863 (1956).
Elion, G.B., Goodman, I., Lange, W., Hitchings, G.H.: Condensed pyrimidine systems. XX. Purines related to 6-mercaptopurine and thioguanine. J. Amer. chem. Soc. 81, 1898–1902 (1959).
Ellis, D.B., LePage, G.A.: Some inhibitory effects of 9-β-D-xylofuranosyladenine, an adenosine analog, on nucleotide metabolism in ascites tumor cells. Molec. Pharmacol. 1, 231–238 (1965).
Falco, E. A., Hitchings, G.H.: Studies on condensed pyrimidine systems. XV. Some pyrazolo-[3, 4-d] pyrimidines. J. Amer. chem. Soc. 78, 3143–1345 (1956).
Farkaš, J., Šorm, F.: Nucleic acid components and their analogues. XXX. The synthesis of psicofuranine. Coll. Czech. Chem. Comm. 28, 882–886 (1963).
Fischer, E.: Über das Purin und seine methyl-derivate. Ber. 31, 2550–2574 (1898).
Flaks, J.G., Erwin, M.J., Buchanan, J.M.: Biosynthesis of purines. XVI. The synthesis of adenosine 5′-phosphate and 5-amino-4-imidazolecarboxamide ribotide by a nucleotide pyrophosphorylase. J. biol. Chem. 228, 201–213 (1957).
Fletcher, H.G., Jr., Diehl, H.W.: De-O-benzylation of benzyl ethers of carbohydrate derivatives by thiols in the presence of boron trifluoride. Carbohyd. Res. 17, 383–391 (1971).
Fleysher, M.H., Bloch, A., Hakala, M.T., NiChol, C.A.: Synthesis and biological activity of some new iV (6)-substituted purine nucleosides. J. med. Chem. 12, 1056–1061 (1969).
Fleysher, M.H., Hakala, M.T., Bloch, A., Hall, R.H.: Synthesis and biological activity of some N (6)-alkyladenosines. J. med. Chem. 11, 717–720 (1968).
Florini, J.R.: Nucleocidin. In: Antibiotics, Vol.1. Berlin-Heidelberg-New York: Springer 1967.
Fox, J. J., Wempen, L., Hampton, A., Doerr, I.L.: Thiation of nucleosides. I. Synthesis of 2-amino-6-mercapto-9-β-D-ribofuranosylpurine (“Thioguanosine”) and related purine nucleosides. J. Amer. chem. Soc. 80, 1669–1675 (1958).
Fukuyama, T.T., Moyed, H.S.: A separate antibiotic-binding site in xanthosine-5′-phosphate aminase: Inhibitor- and substrate-binding studies. Biochemistry 3, 1488–1492 (1964).
Gabriel, S., Colman, J.: Synthesen in der purinreihe. Ber. 34, 1234–1257 (1901).
Gerster, J.F., Jones, J.W., Robins, R.K.: Purine nucleosides. IV. The synthesis of 6-halogenated 9-β-D-ribofuranosylpurines from inosine and guanosine. J. org. Chem. 28, 945–948 (1963).
Gerster, J.F., Carpenter, B., Robins, R.K., Townsend, L.B.: Pyrrolopyrimidine nucleosides. I. The synthesis of 4-substituted 7-(β-D-ribofuranosyl)pyrrolo(2, 3-d)pyrimidines from tubercidin. J. med. Chem. 10, 326–331 (1967).
Giner-Sorolla, A.: The synthesis and properties of 9-β-D-arabinofuranosyl-6-hydroxyl-aminopurine. J. Heterocycl. Chem. 6, 405–406 (1969).
Giner-Sorolla, A., Medrek, L., Bendich, A.: Synthesis and biological activity of 9-β-d-ribofuranosyl-6-hydroxylaminopurine. J. med. Chem. 9, 143–144 (1966 a).
Giner-Sorolla, A., O’Bryant, S., Burchenal, J.H., Bendich, A.: The synthesis and properties of substituted 6-hydroxylaminopurines. Biochemistry 5, 3057–3061 (1966b).
Giner-Sorolla, A., Nanos, C., Burchenal, J.H., Dollinger, M., Bendich, A.: The synthesis and properties of 2, 6-dihydroxylaminopurine and its 9-β-D-ribofuranosyl derivative. J. med. Chem. 11, 52–54 (1968a).
Giner-Sorolla, A., O’Bryant, S. A., Nanos, C., Dollinger, M.R., Bendich, A., Burchenal, J.H.: The synthesis and biological properties of hydroxylaminopurines and related derivatives. J. med. Chem. 11, 521–523 (1968b).
Glaudemans, C.P.J., Fletcher, H.G.: Syntheses with partially benzylated sugars. III. A simple pathway to a “cis-nucleoside” 9-β-D-arabinofuranosyladenine (spongoadenosine). J. org. Chem. 28, 3004–3006 (1963).
Goodman, I., Salce, L., Hitchings, G.H.: Purine thioglycosides. I. S-Glycosides of 6-mer-captopurine. J. med. Chem. 11, 516–521 (1968).
Gordon, M.P., Weliky, V.S., Brown, G.B.: A study of the action of acid and alkali on certain purines and purine nucleosides. J. Amer. chem. Soc. 79, 3245–3250 (1957).
Guarino, A. J.: Angustmycin A. In: Antibiotics, Vol. 1. Berlin-Heidelberg-New York: Springer 1967.
Guarino, A. J., Ibershof, M.L., Swain, R.: Inhibition of protein synthesis in cell-free systems by homocitrullylamino adenosine. Biochim. biophys. Acta (Amst.) 72, 62–68 (1963).
Hampton, A.: Studies of the action of adenylosuccinase with 6-thio analogues of adenylo-succinic acid. J. biol. Chem. 237, 529–535 (1962).
Hampton, A.: Reactions of ribonucleotide derivatives of purine analogues at the catalytic site of inosine 5′-phosphate dehydrogenase. J. biol. Chem. 238, 3068–3074 (1963).
Hampton, A., Maguire, M.H.: Nucleotides. I. Syntheses of 6-chloro-, 6-mercapto-, and 2-amino-6-mercapto-9-β-D-ribofuranosylpurine 5′-phosphates. J. Amer. chem. Soc. 83, 150–157 (1961).
Hampton, A., Paterson, A.R.P.: Conversion of 6-chloropurine to its ribonucleotide by ascites tumor cells. Biochim. biophys. Acta (Amst.) 114, 185–187 (1966).
Hampton, A., Biesele, J.J., Moore, A.E., Brown, G.B.: 6-Furfurylamino-9-β-D-ribo-luranosylpurine: Synthesis and differential toxicity to mammalian cells in vitro, J. Amer. chem. Soc. 78, 5695 (1956).
Hanka, L.J.: Psicofuranine. In: Antibiotics, Vol. 1. Berlin-Heidelberg-New York: Springer 1967.
Henderson, J.F.: Effects of anticancer drugs on biochemical control mechanisms. Progr. exp. Tumor Res. 6, 84–126 (1965).
Henderson, J.F., Paterson, A.R.P., Caldwell, I.C., Hori, M.: Biochemical effects of formycin, an adenosine analog. Cancer Res. 27, 715–719 (1967).
Heppel, L.A.: 5′-Nucleotidase. In: The enzymes, 2nd ed., Vol. 5. New York and London: Academic Press 1961.
Hill, D.L., Bennett, L.L., Jr.: Purification and properties of 5-phosphoribosyl pyrophosphate amidotransferase from adenocarcinoma 755 cells. Biochemistry 8, 122–130 (1969).
Hinshaw, B.C., Gerster, J.F., Robins, R.K., Townsend, L.B.: Pyrrolopyrimidine nucleosides. IV. The synthesis of certain 4, 5-disubstituted-7-(β-D-ribofuranosyl)pyrrolo-(2, 3-d)pyrimidines related to the pyrrolo (2, 3-d)pyrimidine nucleoside antibiotics. J. Heterocycl. Chem. 6, 215–221 (1969).
Hitchings, G.H., Elion, G.B.: Mercapto heterocycles. U.S. Patent 2,697,709 (1954).
Hitchings, G.H., Elion, G.B.: 6-Mercaptopurine from aminoglyoxaline-5-thiocarboxamide. U.S. Patent 2,756,228 (1956).
Hitchings, G.H., Elion, G.B.: Novel 6-chloropurine compounds. U.S.Patent 2,815,346 (1957).
Hitchings, G.H., Elion, G.B.: 1-Methylthioguanine. Brit. Patent 798,165 (1958).
Hitchings, G.H., Elion, G.B.: Purine derivatives. U.S. Patent 3,056,785 (1962).
Hoeksema, H., Slomp, G., Van Tamelen, E.E.: Angustmycin A and decoyinine. Tetrahedron Let. 1787–1795 (1964).
Hoeksema, H., Whitfield, G.B., Rhuland, L.E.: Effect of selective acylation on the oral absorption of a nucleoside by humans. Biochem. biophys. Res. Comm. 6, 213–216 (1961).
Holmes, R.E., Robins, R.K.: Purine nucleosides. VII. Direct bromination of adenosine, deoxyadenosine, guanosine, and related purine nucleosides. J. Amer. chem. Soc. 86, 1242–1245 (1965).
Hori, M., Ito, E., Takita, T., Koyama, G., Takeuchi, T., Umezawa, H.: A new antibiotic, formycin. J. Antibiot. (Tokyo) 17A, 96–99 (1964).
Horwitz, J.P., Vaitkevicius, V.K.: Purin-6-yltrimethylammonium chloride: A new purine antimetabolite. Experientia (Basel) 17, 552–553 (1961).
Huber, G.: Stickstofflost-analoge der purin-reihe. Angew. Chem. 68, 706 (1956).
Ikehara, M.: Studies on coenzyme analogs. II. A convenient synthesis of “Thioinosine”. Chem. pharm. Bull. (Tokyo) 8, 367–368 (1960).
Ikehara, M., Tada, H.: Studies on nucleosides and nucleotides. XXXII. Purine cyclo-nucleosides. 3. Synthesis of 2′-deoxy- and 3′-deoxyadenosine from adenosine. Chem. pharm. Bull. 15, 94–100 (1966).
Ikehara, M., Yamada, S.: Studies of nucleosides and nucleotides. 49. Synthesis of 8-fluoroadenosine. Chem. pharm. Bull. 19, 104–109 (1971).
Ikehara, M., Uesugi, S., Kaneko, M.: Bromination of adenine nucleoside and nucleotide. Chem. Commun. 17–18 (1967).
Ikehara, M., Uno, H., Ishikawa, F.: Studies of nucleosides and nucleotides. XXIII. A versatile method for replacement of 6-hydroxyl group of purine nucleoside. Chem. pharm. Bull. 12, 267–271 (1964).
Ikehara, M., Yamazaki, A., Fujieda, T.: Studies on coenzyme analogs. XIII. Oxidation of methylmercaptopurine and its nucleoside by means of iV-chloro- and N-bromosuccinimide. Chem. pharm. Bull. 10, 1075–1080 (1962).
Imai, K.-L: Studies on nucleic acid antagonists. VII. Synthesis and characterization of 1,4,6-triazaindenes (5H-pyrrolo[3, 2-d]pyrimidines). Chem. pharm. Bull. 12, 1030–1042 (1964).
Isay, O.: Eine synthese des purins. Ber. 39, 259–265 (1906).
Ishido, Y., Matsuba, T., Hosono, A., Fujii, K., Sato, T., Isome, S., Maruyama, A., Kikuchi, Y.: Non-catalytic fusion reaction of l, 2, 3, 5-tetra-O-acetyl-β-D-ribofuranose with purine derivatives. Bull. chem. Soc. Jap. 40, 1007–1009 (1967).
Iwamoto, R.H., Acton, E.M., Goodman, L.: Potential anticancer agents. LXXXI. 2′-Deoxyribofuranosides of 6-mercaptopurine and related purines. J. org. Chem. 27, 3949–3953 (1962).
Iwamura, H., Hashizume, T.: Synthesis in nucleoside antibiotics. III. Synthesis of 4-amino-5-cyano-6-methylmercaptopyrrolo (2, 3-d) pyrimidine-7-β-d-ribosides (toyocamycin analogs). Agr. biol. Chem. 32, 1010–1015 (1968a).
Iwamura, H., Hashizume, T.: Synthesis in nucleoside antibiotics. II. Facile synthesis of nebularine and its analogs by a modified fusion procedure. J. org. Chem. 33, 1796–1799 (1968b).
Jain, P.C., Chatterjee, S.K., Anand, N.: Potential purine antagonists: Part VII—Synthesis of 3-β-D-ribofuranosyl-7-aminoimidazo(4, 5–b) pyridine (1-deazaadenosine). Ind. J. Chem. 4, 403–405 (1966).
Jenkins, I.D., Verheyden, J.P.H., Mopfatt, J.G.: Synthesis of the nucleoside antibiotic nucleocidin. J. Amer. chem. Soc. 93, 4323–4324 (1971).
Johnson, J.A., Jr., Thomas, H.J.: Synthesis of potential anticancer agents. II. 6-Mercapto-9-β-D-ribofuranosylpurine. J. Amer. chem. Soc. 78, 3863 (1956).
Johnson, J.A., Jr., Schaeffer, H. J., Thomas, H.J.: Synthesis of potential anticancer agents. XIII. Ribosides of 6-substituted purines. J. Amer. chem. Soc. 80, 699–702 (1958).
Johnston, T.P., Fikes, A.L., Montgomery, J.A.: The structure of the tricyclic purine derived from the purin-6-yl analog of nitrogen mustard. J. org. Chem. 27, 973–976 (1962).
Johnston, T.P., Holum, L.B., Montgomery, J.A.: Synthesis of potential anticancer agents. XVI. S-Substituted derivatives of 6-mercaptopurine. J. Amer. chem. Soc. 80, 6265–6271 (1958).
Johnston, T.P., McCaleb, G.S., Montgomery, J.A.: The synthesis of antineoplastic agents. XXXII. N-Nitrosoureas. I. J. med. Chem. 6, 669–681 (1963).
Kaczka, E.A., Trenner, N.R., Arison, B., Walker, R.W., Folkers, K.: Identification of cordycepin, a metabolite of Cordyceps militaris as 3′-deoxyadenosine. Biochem. biophys. Res. Commun. 14, 456 (1964).
Keller, F., Bunker, J.E.: 6, 6′-Dithiobispurinyl nucleosides. J. med. Chem. 12, 1117–1118 (1969).
Kenner, G. W., Lythgoe, B., Todd, A.R.: Experiments on the synthesis of purine nucleosides. Part XVII. The preparation of 4-glycofuranosidaminopyrimidines, and a synthesis of 9-L-arabofuranosido-2-methylthioadenine. J. chem. Soc. 957–964 (1948).
Kissman, H.M., Weiss, M.J.: Kinetin riboside and related nucleosides. J. org. Chem. 21, 1053–1055 (1956).
Kissman, H.M., Dacks, C.P., Baker, B.R.: Puromycin synthetic studies. XI. D-Ribo-furanosyl derivatives of 6-methylaminopurine. J. Amer. chem. Soc. 77, 18–24 (1955).
Kögl, F., van der Want, G.M., Salemink, C.A.: Über 1-des-aza-adenin (7-amino-l-imidazo (b)pyridin). 1. Mitteilung über des-aza-purin derívate. Rec. trav. chim. 67, 29–44 (1948).
Koppel, H.C., Robins, R.K.: Potential purine antagonists. XIII. Synthesis of some 8-methyl-purines. J. org. Chem. 23, 1457–1460 (1958).
Koppel, H.C., O’Brien, D.E., Robins, R.K.: Potential purine antagonists. XVIII. Preparation of some 6-alkylthiopurines and 4-alkylthiopyrazolo[3, 4-d]pyrimidines. J. org. Chem. 24, 259–261 (1959a).
Koppel, H.C., O’Brien, D.E., Robins, R.K.: Potential purine antagonists. XIX. Synthesis of some 9-alkyl(aryl)-2-amino-6-substituted purines and related v-triazolo[d]pyrimidines. J. Amer. chem. Soc. 81, 3046–3051 (1959b).
Koppel, H.C., Springer, R.H., Robins, R.K., Cheng, C.C.: Pyrimidines. VIII. Pyrimidine derivatives of thioguanine. J. med. pharm. Chem. 5, 639–641 (1962 a).
Koppel, H.C., Springer, R.H., Robins, R.K., Schneider, F.H., Cheng, C.C.: Synthesis of some 8-substituted bis (β-chloroethyl) amino derivatives of naturally occurring N-methylated purines. J. org. Chem. 27, 2173–2177 (1962b).
Kornberg, A., Lieberman, L., Simms, E.S.: Enzymatic synthesis of purine nucleotides. J. biol. Chem. 215, 417–427 (1955).
Kotva, R., Semonský, M., Vachek, J., Jelínek, V.: Substances with antineoplastic activity. 41. δ-(8-Aza-6-purinylthio) valeric acid and some of its 9-alkyl and 9-cycloalkyl derivatives. Coll. Czech. Chem. Commun. 35, 1610–1613 (1970).
Kotva, R., Černý, A., Semonský, M., Vaohek, J., Jelínek, V.: Substances with antineo-plastic activity. XXXII. Some 9-alkyl and 9-cycloalkyl-6-(4-carboxybutylthio)purines. Coll. Czech. Chem. Commun. 34, 2114–2121 (1969).
Kream, J., Chargaff, E.: Procedures for the study of purine and pyrimidine deaminases in small amounts. J. Amer. chem. Soc. 74, 4274–4277 (1952).
Krenitsky, T.A., Papaioannou, R., Elion, G.B.: Human hypoxanthine phosphoribosyl-transferase. I. Purification, properties, and specificity. J. biol. Chem. 244, 1263–1270 (1969).
Krenitsky, T.A., Elion, G.B., Henderson, A.M., Hitchings, G.H.: Inhibition of human purine nucleoside Phosphorylase, studies with intact erythrocytes and the purified enzyme. J. biol. Chem. 243, 2876–2881 (1968).
Krenitsky, T.A., Elion, G.B., Strelitz, R.A., Hitchings, G.H.: Ribonucleosides of allo-purinol and oxoallopurinol. J. biol. Chem. 242, 2675–2682 (1967).
Kuramitsu, H., Moyed, H.S.: A separate antibiotic binding site in xanthosine 5′-phosphate aminase. J. biol. Chem. 241, 1596–1601 (1966).
Kusaka, T., Yamamoto, H., Shibata, M., Muroi, M., Kishi, T., Mizuno, K.: Streptowyces citricolor nov. sp. and a new antibiotic, aristeromycin. J. Antibiot. (Tokyo) 255–263 (1968).
Laster, W.R., Jr., Mayo, J.G., Simpson-Herren, L., Griswold, D.P., Jr., Lloyd, H.H., Schabel, F.M., Jr., Skipper, H.E.: Success and failure in the treatment of solid tumors. II. Kinetic parameters and “cell cure” of moderately advanced carcinoma 755. Cancer Chemother. Rep. 53, 169–188 (1969).
Lee, W.W., Martinez, A.P., Tong, G.L., Goodman, L.: Simultaneous formation of both α-and β-nucleosides by the fusion method. Chem. Ind. (Lond.) 2007–2008 (1963).
Lee, W.W., Tong, G.L., Blackford, R.W., Goodman, L.: Nucleosides from 3-deoxy-3-methylamino-D-ribofuranose. J. org. Chem. 35, 3808–3814 (1970).
Lee, W.W., Benitez, A., Anderson, C.D., Goodman, L., Baker, B.R.: Potential anticancer agents. LV. Synthesis of 3′-amino-2′,3′-dideoxyadenosine and related analogs. J. Amer. chem. Soc. 83, 1906–1911 (1961).
Leonard, N.J., Achmatowicz, S., Loeppky, R.N., Carraway, K.L., Grimm, W.A.H., Szweykowska, A., Hamzi, H.Q., Skoog, F.: Development of cytokinin activity by rearrangement of 1-substituted adenines to 6-substituted aminopurines. Inactivation by N6, l-cyclization. Proc. nat. Acad. Sci. (Wash.) 56, 709–716 (1966).
Lepage, G.A.: Incorporation of 6-thioguanine into nucleic acids. Cancer Res. 20, 403–408 (1960).
Lepage, G.A.: The metabolism of α-2′-deoxythioguanosine in murine tumor cells. Can. J. Biochem. 46, 655–661 (1968).
Lettré, H., Ballweg, H.: Ribosides of some cytotoxic purine derivatives. Ann. Chem., Liebigs. 656, 158–162 (1962).
Levin, G., Sugiura, K., Brown, G.B.: A nitrogen mustard derivative of 6-mercaptopurine. J. med. Chem. 7, 357–358 (1964).
Lewis, L.R., Robins, R.K., Cheng, C.C.: The preparation and antitumor properties of acylated derivatives of 6-thiopurine ribosides. J. med. Chem. 7, 200–204 (1964).
Lewis, L.R., Schneider, P.H., Robins, R.K.: Purine nucleosides. II. The preparation of 6-substituted 9-(tetrahydro-2-furyl) purines and 6-substituted 9-(tetrahydro-2-thienyl)-purines as models of purine deoxynucleosides. J. org. Chem. 26, 3837–3842 (1961).
Lewis, L.R., Noell, C.W., Beaman, A.G., Robins, R.K.: The preparation and antitumor activity of certain derivatives of 6-mercaptopurine. J. med. pharm. Chem. 5, 607–617 (1962).
Lin, H.H., Price, C.C.: Some 6-bis (2-chloroethyl)aminoalkyladenines. J. org. Chem. 26, 264–265 (1961).
Lindberg, B., Klenow, H., Hansen, K.: Some properties of partially purified mammalian adenosine kinase. J. biol. Chem. 242, 350–356 (1967).
Lepkin, D., Howard, F.B., Nowotny, D., Sano, M.: The iodination of nucleosides and nucleotides. J. biol. Chem. 238, 2249–2250 (1963).
Long, R. A., Lewis, A.F., Robins, R.K., Townsend, L.B.: Pyrazolopyrimidine nucleosides. Part II. 7-Substituted 3-β-D-ribofuranosylpyrazolo[4, 3-d]pyrimidines related to and derived from the nucleoside antibiotics formycin and formycin B. J. chem. Soc. 2443–2446 (1971).
Mandel, H.G.: Comparative actions of some purine analogues on growing Bacillus cereus. Fed. Proc. 26, 905–906 (1967).
Martinez, A.P., Lee, W.W.: Pentopyranosyl nucleosides. II. 6-Mercapto and other substituted derivatives of 9-D-arabino- and 9-D-xylopyranosylpurine. Synthesis and spectral properties. J. org. Chem. 34, 416–421 (1969).
Mautner, H.G.: The synthesis and properties of some selenopurines and selenopyrimidines. J. Amer. chem. Soc. 78, 5292–5294 (1956).
Mautner, H.G., Chu, S.-H., Jaffe, J.J., Sartorelli, A.C.: The synthesis and antineoplastic properties of selenoguanine, selenocytosine and related compounds. J. med. Chem. 6, 36–39 (1963).
McCarthy, J.R., Robins, R.K., Robins, M.J.: Purine nucleosides. XXII. The synthesis of angustmycin A (decoyinine) and related unsaturated nucleosides. J. Amer. chem. Soc. 90, 4993–4999 (1968).
McCollister, R.J., Gilbert, W.R., Ashton, D.M., Wyngaarden, J.B.: Pseudofeedback inhibition of purine synthesis by 6-mercaptopurine ribonucleotide and other purine analogues. J. biol. Chem. 239, 1560–1563 (1964).
Miech, R.P., York, R., Parks, R.E., Jr.: Adenosine triphosphate-guanosine 5′-phosphate phosphotransferase. II. Inhibition by 6-thioguanosine 5′-phosphate of the enzyme isolated from hog brain and sarcoma 180 ascites cells. Molec. Pharmacol. 5, 30–37 (1969).
Miech, R.P., Parks, R.E., Jr., Anderson, J.H., Sartorelli, A.C.: An hypothesis on the mechanism of action of 6-thioguanine. Biochem. Pharmacol. 16, 2222–2227 (1967).
Milne, G.H., Townsend, L.B.: The synthesis and chemical reactivity of 6-selenoguanosine and certain related derivatives. J. Heterocycl. Chem. 8, 379–382 (1971).
Mitchell, J.H., Jr., Skipper, H.E., Bennett, L.L., Jr.: Investigation of the nucleic acids of viscera and tumor tissue from animals injected with radioactive 8-azaguanine. Cancer Res. 10, 647–649 (1950).
Mizuno, Y., Itoh, T., Saito, K.: Studies on condensed systems of aromatic nitrogenous series. XXIII. Synthesis of l-(β-D-ribofuranosyl)-l H-imidazo[4, 5-c]pyridines. J. org. Chem. 29, 2611–2615 (1964).
Mizuno, Y., Ikekawa, N., Itoh, T., Saito, K.: Studies on condensed aromatic nitrogenous compounds. XXV. Product distribution in ribosylation of purines and deazapurines by the mercuri method. J. org. Chem. 30, 4066–4071 (1965).
Mizuno, Y., Ikehara, M., Watanabe, K.A., Suzaki, S.: Synthetic studies of potential antimetabolites. X. Synthesis of 4-hydroxy-7- β-D-ribofuranosyl-7 H-pyrrolo[2, 3-d]pyrimidine, a tubercidin analog. J. org. Chem. 28, 3331–3336 (1963).
Montgomery, J.A.: Synthesis of potential anticancer agents. I. Chloropurines. J. Amer. chem. Soc. 78, 1928–1930 (1956).
Montgomery, J.A.: The biochemical basis for the drug actions of purines. Progr. med. Chem. 7, 69–122 (1970).
Montgomery, J.A., Hewson, K.: Synthesis of potential anticancer agents. X. 2-Fluoro-adenosine. J. Amer. chem. Soc. 79, 4559 (1957).
Montgomery, J.A., Hewson, K.: Synthesis of potential anticancer agents. XX. 2-Fluoro-purines. J. Amer. chem. Soc. 82, 463–468 (1960).
Montgomery, J.A., Hewson, K.: 7-Substituted-7 H-purines. J. org. Chem. 26, 4469–4472 (1961).
Montgomery, J.A., Hewson, K.: The synthesis of 2-bromoadenosine. J. Heterocycl. Chem. 1, 213–214 (1964).
Montgomery, J.A., Hewson, K.: Deaza analogs of 6-mercaptopurine. J. med. Chem. 8, 708–710 (1965a).
Montgomery, J.A., Hewson, K.: New approaches to the synthesis of 5 H-pyrrolo[3, 2-d]-pyrimidines. J. org. Chem. 30, 1528–1532 (1965b).
Montgomery, J.A., Hewson, K.: l-Deaza-6-methylthiopurine ribonucleoside. J. med. Chem. 9, 354–357 (1966a).
Montgomery, J.A., Hewson, K.: 2-Deaza-6-methylthiopurine ribonucleoside. J. med. Chem. 9, 105–107 (1966b).
Montgomery, J.A., Hewson, K.: Analogs of tubercidin. J. med. Chem. 10, 665–667 (1967).
Montgomery, J.A., Hewson, K.: A convenient method for the synthesis of 2-fluoroadenosine. J. org. Chem. 33, 432–434 (1968a).
Montgomery, J.A., Hewson, K.: Analogs of 6-methyl-9-β-D-ribofuranosylpurine. J. med. Chem. 11, 48–52 (1968b).
Montgomery, J.A., Hewson, K.: Nucleosides of 2-fluoroadenine. J. med. Chem. 12, 498–504 (1969).
Montgomery, J.A., Hewson, K.: 2-Fluoropurine ribonucleosides. J. med. Chem. 13, 427–430 (1970).
Montgomery, J.A., Holum, L.B.: Synthesis of potential anticancer agents. III. Hydrazino analogs of biologically active purines. J. Amer. chem. Soc. 79, 2185–2188 (1957).
Montgomery, J.A., Temple, C., Jr.: Synthesis of potential anticancer agents. IX. 9-Ethyl-6-substituted purines. J. Amer. chem. Soc. 79, 5238–5242 (1957).
Montgomery, J.A., Temple, C., Jr.: Synthesis of potential anticancer agents. XII. 9-Alkyl-6-substituted-purines. J. Amer. chem. Soc. 80, 409–411 (1958).
Montgomery, J.A., Temple, C., Jr.: Synthesis of potential anticancer agents. XXII. Reactions of orthoesters with 4, 5-diaminopyrimidines. J. org. Chem. 25, 395–399 (1960).
Montgomery, J.A., Temple, C., Jr.: Synthesis of potential anticancer agents. XXVI. The alkylation of 6-chloropurine. J. Amer. chem. Soc. 83, 630–635 (1961).
Montgomery, J.A., Thomas, H.J.: Synthesis of potential anticancer agents. XXVII. The ribonucleotides of 6-mercaptopurine and 8-azaguanine. J. org. Chem. 26, 1926–1929 (1961).
Montgomery, J.A., Thomas, H. J.: Directive influences in the preparation of purine nucleo-sides. J. org. Chem. 28, 2304–2310 (1963).
Montgomery, J.A., Thomas, H.J.: The use of the allyl group as a blocking group for the synthesis of iV-substituted purines. J. org. Chem. 30, 3235–3236 (1965).
Montgomery, J.A., Thomas, H.J.: 2-Azaadenosine (4-amino-7-β-D-ribofuranosyl-7 H-imidazo-[4, 5-d]-v-triazine). Chem. Commun. 458 (1969).
Montgomery, J.A., Thomas, H.J.: A new approach to the synthesis of nucleosides of 8-azapurines (l-glycosyl-v-triazolo[4, 5-d]pyrimidines). J. org. Chem. 36, 1962–1967 (1971).
Montgomery, J.A., Thomas, H.J.: Nucleosides of 8-azapurines (v-triazolo [4, 5-d]pyrimidines). J. med. Chem. 15, 305–307 (1972a).
Montgomery, J.A., Thomas, H.J.: Nucleosides of 2-azapurines and certain ring analogs. J. med. Chem. 15, 182–187 (1972b).
Montgomery, J.A., Clayton, S.J., Fitzgibbon, W.E., Jr.: The ribonucleosides of 4-amino-pyrazolo [3, 4-d]pyrimidines. J. Heterocycl. Chem. 1, 215–216 (1964).
Montgomery, J.A., Hewson, K., Temple, C., Jr.: Synthesis of potential anticancer agents. XXX. (1-aziridinyl) purines. J. med. Pharm. Chem. 5, 15–24 (1962).
Montgomery, J.A., Johnston, T.P., Shealy, Y.F.: Drugs for neoplastic diseases. In: Medicinal chemistry, 3rd. ed. New York: Wiley Interscience 1970a.
Montgomery, J.A., Thomas, H. J., Clayton, S.J.: A convenient synthesis of 8-azaadenosine. J. Heterocycl. Chem. 7, 215–217 (1970b).
Montgomery, J.A., Thomas, H.J., Schaeffer, H.J.: Synthesis of potential anticancer agents. XXVIII. Simple esters of 6-mercaptopurine ribonucleotide. J. org. Chem. 26, 1929–1933 (1961a).
Montgomery, J.A., Johnston, T.P., Gallagher, A., Stringfellow, C.R., Schabel, F.M., Jr.: A comparative study of the anticancer activity of some S-substituted derivatives of 6-mercaptopurine and their ribonucleosides. J. med. pharm. Chem. 3, 265–288 (1961b).
Montgomery, J.A., Dixon, G.J., Dulmadge, E.A., Thomas, H.J., Broökman, R.W., Skipper, H.E.: Inhibition of 6-mercaptopurine-resistant cancer cells in culture by bis (thioinosine)-5′-5‴-phosphate. Nature (Lond.) 199, 769–772 (1963).
Morton, G.O., Lancaster, J.E., Van Lear, G.E., Fulmor, W., Meyer, W.E.: The structure of nucleocidin. III. (A new structure). J. Amer. chem. Soc. 91, 1535–1537 (1969).
Murray, D.H., Prokop, J.: Synthesis of 3′-deoxynucleosides. II. Synthesis of 9-(3-deoxyaldo-furanosyl) adenines derived from 3-deoxy-D-glucose. J. pharm. Sci. 54, 1468–1473 (1965).
Nathans, D.: Puromycin. In: Antibiotics, vol.1. Berlin-Heidelberg-New York: Springer-Verlag, 1967.
Nierlich, D.P., Magasanik, B.: Eegulation of purine ribonucleotide synthesis by end product inhibition. The effect of adenine and guanine ribonucleotides on the 5′-phosphoribosylpyro-phosphate amidotransferase of Aerobacter aerogenes. J. biol. Chem. 240, 358–365 (1965).
Nishimura, T., Iwai, L.: Studies on synthetic nucleosides. II. Novel synthesis of pyrimidine glucosides. Chem. pharm. Bull. 12, 357–361 (1964).
Nishimura, H., Katagiri, K., Sato, K., Mayama, M., Shimaoka, N.: Toyocamycin, a new antibiotic. J. Antibiot. (Tokyo) 9, 60–62 (1956).
Noell, C.W., Kobins, R.K.: Potential purine antagonists. XIV. Synthesis of some 4-(substituted amino)pyrazolo[3, 4-d]pyrimidines. J. org. Chem. 23, 1547–1550 (1958).
Noell, C.W., Robins, R.K.: Potential purine antagonists. XX. The preparation and reactions of some methylthiopurines. J. Amer. chem. Soc. 81, 5997–6001 (1959).
Noell, C.W., Robins, R.K.: Potential purine antagonists. XXXI. The preparation of certain 9-alkyl-2-amino-6-purinethiols and related derivatives as antitumor agents. J. med. pharm. Chem. 5, 558–588 (1962a).
Noell, C.W., Robins, R.K.: The antitumor activity of 2-amino-6-alkylthio-9-β-D-ribo-furanosylpurines and related derivatives of 2-amino-6-purinethiol (thioguanine). J. med. pharm. Chem. 5, 1074–1085 (1962b).
Noell, C.W., Smith, D.W., Robins, R.K.: Synthesis and antitumor activity of 2-amino-l-methylpurine-6-thione. J. med. pharm. Chem. 5, 996–999 (1962).
O’Brien, D.E., Westover, J.D., Robins, R.K., Cheng, C.C.: Synthesis and antitumor activity of 9-substituted nitrogen mustard derivatives of 6-alkylthiopurines. J. med. Chem. 8, 182–187 (1965).
Overgaard-Hansen, K.: The inhibition of 5-phosphoribosyl-1-pyrophosphate formation by cordycepin triphosphate in extracts of Ehrlich ascites tumor cells. Biochim. biophys. Acta (Amst.) 80, 504–507 (1964).
Paterson, A.R.P., Sutherland, A.: Metabolism of 6-mercaptopurine ribonucleoside by Ehrlich ascites carcinoma cells. Can. J. Biochem. 42, 1415–1423 (1964).
Perini, F., Hampton, A.: A simplified procedure for the synthesis of 6-methylthiopurine ribonucleoside 5′-phosphates. J. Heterocycl. Chem. 7, 969–971 (1970).
Pfleiderer, W., Mosthaf, H.: Untersuchungen in der pyrimidinreihe, II. Über die Darstellung von Pyrido-[3.2-d]- und pyrrolo-[3.2-d]-pyrimidinen. Chem. Ber. 90, 738–745 (1957).
Pierre, K.J., LePage, G.A.: Formation of inosine-5′-monophosphate by a kinase in cell-free extracts of Ehrlich ascites cells in vitro. Proc. Soc. exp. Biol. N. Y. 127, 432–440 (1968).
Pierre, K.J., Kimball, A.P., LePage, G.A.: The effect of structure on nucleoside kinase activity. Can. J. Biochem. 45, 1619–1632 (1967).
Pike, J.E., Slechta, L., Wiley, P.F.: Tubercidin and related compounds. J. Heterocycl. Chem. 1, 159–161 (1964).
Porter, J.N., Hewitt, R.L, Hesseltine, C.W., Krupka, G., Lowery, J.A., Wallace, W.S., Bohonos, N., Williams, J.H.: Achromycin: A new antibiotic having trypanocidal properties. Antibiot. Chemother. 2, 409–410 (1952).
Rao, K.V., Renn, D.W.: BA-90912: An antibiotic substance. Antimicrob. Agents Chemother. 77–79 (1963).
Reist, E.J., Bartuska, V.J., Goodman, L.: Sodium-liquid ammonia debenzylation in nucleoside synthesis. J. org. Chem. 29, 3725–3726 (1964).
Reist, E.J., Calkins, D.F., Goodman, L.: iV-Oxides of 9-(β-D-xylofuranosyl) adenine and 9-(β-D-arabinofuranosyl) adenine. J. med. Chem. 10, 130 (1967 a).
Reist, E.J., Calkins, D.F., Goodman, L.: Purine nucleosides of ß-D-lyxofuranose. J. org. Chem. 32, 169–173 (1967 b).
Reist, E.J., Hart, P.A., Goodman, L., Baker, B.R.: Potential anticancer agents. LI. Synthesis of 2-amino-9-(5′-deoxy-β-D-ribofuranosyl)-9-H-purine-6-thiol. J. org. Chem. 26, 1557–1562 (1961).
Reist, E.J., Benitez, A., Goodman, L., Baker, B.R., Lee, W.W.: Potential anticancer agents. LXXVI. Synthesis of purine nucleosides of β-D-arabinofuranose. J. org. Chem. 27, 3774–3779 (1962a).
Reist, E.J., Benitez, A., Lee, W.W., Baker, B.R., Goodman, L.: Potential anticancer agents. LXXVIL Synthesis of nucleosides of purine-6-thiol (6-mercaptopurine) containing “fraudulent” sugars. J. org. Chem. 27, 3279–3283 (1962b).
Revankar, G.R., Townsend, L.B.: Pyrazolopyrimidine nucleosides. Part. I. Synthesis of pyrazolopyrimidine nucleosides related to the nucleoside antibiotic tubercidin. J. chem. Soc. 2440–2442 (1971).
Robins, R.K.: Potential purine antagonists. I. Synthesis of some 4, 6-substituted pyrazolo-[3, 4-d]pyrimidines. J. Amer. chem. Soc. 78, 784–790 (1956).
Robins, R.K.: A new synthesis of chloropurine ribonucleosides. J. Amer. chem. Soc. 82, 2654–2655 (1960).
Robins, R.K., Dille, K.J., Willits, C.H., Christensen, B.E.: Purines. II. The synthesis of certain purines and the cyclization of several substituted 4, 5-diaminopyrimidines. J. Amer. chem. Soc. 75, 263–266, 6359 (1959).
Robins, R.K., Furcht, F.W., Grauer, A.D., Jones, J.W.: Potential purine antagonists. II. Synthesis of some 7- and 5,7-substituted pyrazolo[4, 3-d]pyrimidines. J. Amer. chem. Soc. 78, 2418–2422 (1956).
Robins, R.K., Godefroi, E.F., Taylor, E.C., Lewis, L.R., Jackson, A.: Purine nucleosides. I. The synthesis of certain 6-substituted-9-(tetrahydro-2-pyranyl) purines as models of purine deoxynucleosides. J. Amer. chem. Soc. 83, 2574–2579 (1961).
Roblin, R.O., Jr., Lampen, J.O., English, J.P., Cole, Q.P., Vaughn, J.R., Jr.: Studies in chemotherapy. VIII. Methionine and purine antagonists and their relation to the sulfonamides. J. Amer. chem. Soc. 67, 290–294 (1945).
Rose, F.L.: 1:2:4:6-Tetraazaindenes and 1:4:6-triazaindan-2-ones from 5-aminopyrimidines. J. chem. Soc. 4116–4126 (1954).
Rottman, F., Guarino, A.J.: The inhibition of phosphoribosylpyrophosphate amidotransferase activity by cordycepin monophosphate. Biochim. biophys. Acta (Amst.) 89, 465–472 (1964).
Rousseau, R. J., Townsend, L.B., Robins, R.K.: The synthesis of 4-amino-β-D-ribofuranosyl-imidazo [4, 5-c] pyridine (3-deazaadenosine) and related nucleotides. Biochemistry 5, 756–760 (1966).
Roy, J.K., Haavik, A.G., Parks, R.E., Jr: Nucleotides of adenine analogs. Proc. Amer. Assoc. Cancer Res. 3, 146 (1960).
Roy, J.K., Kvam, D.C., Dahl, J.L., Parks, R.E., Jr.: Effect of triphosphate nucleosides of 8-azaguanine, 6-thioguanine, and 6-mercaptopurine on amino acid incorporation in vitro into microsomal protein. J. biol. Chem. 236, 1158–1162 (1961).
Salemink, C. A., van der Want, G.M.: Über 3-desaza-adenin (4-amino-l-imidazo-(c)-pyridin) und verwandte basen. 3. Mitteilung über desazapurin-derivate. Rec. trav. chim. 68, 1013–1029 (1949).
Salser, J., Hutchison, D. J., Balis, M.E.: Studies on the mechanism of action of 6-mercapto-purine in cell-free preparations. J. biol. Chem. 235, 429–432 (1960).
Saneyoshi, M.: Synthetic nucleosides and nucleotides. 8. Direct synthesis of the 5′-phosphate of 4-thiouridine, 6-thioinosine and 6-thioguanosine from the corresponding oxy nucleotide via Lathiation procedure. Chem. pharm. Bull. 19, 493–498 (1971).
Sato, K., LePage, G.A., Kimball, A.P.: The metabolism of 9-β-D-xylofuranosyl-6-mercapto-purine. Cancer Res. 26, 741–747 (1966).
Sato, T., Shimadate, T., Ishido, Y.: A new method for syntheses of purine nucleosides. Parts 1 and 2. Nippon Kagaku Zasshi 81, 1440–1444 (1960).
Sawa, T., Fukagawa, Y., Homma, L, Wakashiro, T., Takeuchi, T., Hori, M., and Komai, T.: Metabolic conversion of formycin B to formycin A and to oxoformycin B in Nocardia interforma. J. Antibiot. 21, 334–339 (1968).
Scannell, J.P., Hitchings, G.H.: Thioguanine in deoxyribonucleic acid from tumors of 6-mercaptopurine-treated mice. Proc. Soc. exp. Biol. N. Y. 122, 627–629 (1966).
Schaeffer, H.J., Thomas, H. J.: Synthesis of potential anticancer agents. XIV. Ribosides of 2, 6-disubstituted purines. J. Amer. chem. Soc. 80, 3738–3742 (1958).
Schmidt, L.H., Montgomery, J.A., Laster, W.R., Jr., Schabel, P.M., Jr.: Combination therapy with arabinosyl cytosine and thioguanine. Proc. Amer. Assoc. Cancer Res. 11, 70 (1970).
Schnebli, H.P., Hill, D.L., Bennett, L.L., Jr.: Purification and properties of adenosine kinase from human tumor cells of type H.Ep. No. 2. J. biol. Chem. 242, 1997–2004 (1967).
Schroeder, W., Hoeksema, H.: A new antibiotic, 6-amino-9-D-psicofuranosylpurines. J. Amer. chem. Soc. 81, 1767–1768 (1959).
Semonský, M., Černý, A., Jelínek, V.: Substanzen mit antineoplastischer Wirksamkeit. II. Einige 6-carboxylalkylthiopurine. Coll. Czech. Chem. Commun. 25, 1091–1099 (1960).
Semonský, M., Černý, A., Jelínek, V.: Substances with antineoplastic activity. 29. N-(δ-(6- purinylthio)valeryl) amino acids and analogous dipeptide and trigflycine derivatives. Arzneim.-Forsch. 20, 316–323 (1970).
Semonsky, M., Kotva, R., Vachek, J., Jelinek, V.: Substances with antineoplastic activity. XXVII. Some α-substitution derivatives of δ-(6-purinylthio) valeric and ε-(6-purinylthio)-caproic acids. Coll. Czech. Chem. Commun. 33, 3823–3832 (1968).
Shaw, E.: A new synthesis of the purines adenine, hypoxanthine, xanthine, and isoguanine. J. biol. Chem. 185, 439–447 (1950).
Shaw, E., Woolley, D.W.: A new and convenient synthesis of 4-amino-5-imidazolecarbox-amide. J. biol. Chem. 181, 89–93 (1949).
Shaw, G., Butler, D.N.: Purines, pyrimidines, and glyoxalines. Part XIV. The preparation and some reactions of α-amino-α-cyanothioacetamide, leading to 6-mercaptopurines and adenines. J. chem. Soc. 4040–4045 (1959).
Shealy, Y.F., Clayton, J.D.: 9-[β-Dl-2 α, 3α-Dihydroxy-4 β-(hydroxymethyl)cyclopentyl]-adenine, the carbocyclic analog of adenosine. J. Amer. chem. Soc. 88, 3885–3887 (1966).
Shealy, Y.F., Clayton, J.D., O’Dell, C. A., Montgomery, J. A.: v-Triazolo [4, 5-d] pyrimidines II. O-Substituted derivatives of 8-azaguanine and 8-azahypoxanthine. J. org. Chem. 27, 4518–4523 (1962).
Shealy, Y.F., Struck, R.F., Clayton, J.D., Montgomery, J.A.: v-Triazolo[4, 5-d]pyrimidines. I. Synthesis and nucleophilic substitution of 7-chloro derivatives of 3-substituted v-triazolo[4, 5-d]pyrimidines. J. org. Chem. 26, 4433–4440 (1961).
Shigeura, H.T., Sampson, S.D., Melon, M.L.: Limited phosphorylation of some 6-methyl-aminopurine nucleosides. Arch. Biochem. Biophys. 115, 462–467 (1967).
Shigeura, H.T., Boxer, G. E., Sampson, S.D., Meloni, M.L.: Metabolism of 2-fluoroadenosine by Ehrlich ascites cells. Arch. Biochem. Biophys. 111, 713–719 (1965).
Shimizu, B., Miyaki, M.: Glycosyl migration of derivatives of 3-isoadenosine and its 5′-phosphate. Chem. Ind. 664–665 (1966).
Skinner, G.G., Claybrook, J.R., Ross, D.L., Shive, W.: Synthesis of some α- and β-(6-purinylthio)carboxylic acids. J. org. Chem. 23, 1223–1224 (1958).
Skinner, C.G., Ham, E.G., Fitzgerald, D.C., Jr., Eakin, R.E., Shive, W.: Synthesis and biological activity of some 6-(substituted) thiopurines. J. org. Chem. 21, 1330–1332 (1956a).
Skinner, O.G., Shive, W., Ham, R.G., Fitzgerald, D.C., Jr., Eakin, R.E.: Effects of some 6-(substituted)-purines on regeneration of hydra. J. Amer. chem. Soc. 78, 5097–5100 (1956b).
Sowa, W.: Convenient synthesis of 3-amino-3-deoxy-D-ribose. Can. J. Chem. 46, 1586–1589 (1968).
Sutcleffe, E. Y., Zee-Cheng, K. Y., Cheng, C.C., Robins, R.K.: Potential purine antagonists. XXXII. The synthesis and antitumor activity of certain compounds related to 4-amino-pyrazolo[3, 4-d]pyrimidine. J. med. pharm. Chem. 5, 588–607 (1962).
Tanaka, K., Sugawa, T., Nakamori, R., Sanno, Y., Ando, Y., Imai, K.-L: Studies on nucleic acid antagonists. VI. Synthesis of 1,4,6-triazaindenes (5H-pyrrolo [3, 2-d] pyrimidines). Chem. pharm. Bull. 12, 1024–1030 (1964).
Tanaka, N., Nishimura, T., Yamaguchi, H., Umezawa, H.: Activity of angustmycins against experimental infections and transplantable tumors. J. Antibiot. (Tokyo) 14, 98–102 (1961).
Taylor, E.C., Vogl, O., Cheng, C.C.: Studies in purine chemistry. II. A facile synthesis of 2-substituted adenines. J. Amer. chem. Soc. 81, 2442–2448 (1959).
Temple, C., Jr., Montgomery, J.A.: Some unusual reactions of 6-chloropurines with thioureas. 6-Alkylthiopurines and 2, 2-diamino-2 H-thiazolo[3, 4, 5-gh]purines from 2-(purin-6-yl)-2-thiopseudoureas. J. org. Chem. 31, 1417–1422 (1966).
Temple, C., Jr., Kussner, C.L., Montgomery, J.A.: Synthesis of potential anticancer agents. XXXI. 9-Alkyl-9 H-purines. J. med. pharm. Chem. 5, 866–870 (1962).
Temple, C., Jr., Kussner, C.L., Montgomery, J.A.: Lipid-soluble derivatives of 6-mercapto-purine. J. med. Chem. 11, 41–44 (1968).
Thomas, H.J., Montgomery, J.A.: Complex esters of thioinosinic-(5′) acid. J. med. pharm. Chem. 5, 24–32 (1962).
Thomas, H.J., Montgomery, J.A.: Derivatives and analogs of 6-mercaptopurine ribo-nucleotide. J. med. Chem. 11, 44–48 (1968).
Thomas, S.O., Singleton, V.L., Lowery, J.A., Sharpe, R.W., Preuss, L.M., Porter, J.N., Mowat, J.H., Bohonos, N.: Nucleocidin, a new antibiotic with activity against trypano-somes. Antibiot. Ann. 716–721 (1956–1957).
Todd, A., Ulbricht, T.L.V.: Deoxynucleosides and related compounds. Part IX. A synthesis of 3′-deoxyadenosine. J. chem. Soc. 3275–3277 (1960).
Tolman, R.L., Robins, R.K., Townsend, L.B.: Pyrrolopyrimidine nucleosides. II. The total synthesis of 7-β-D-ribofuranosylpyirolo(2, 3-d)pyrimidines related to toyocamycin. J. Heterocycl. Chem. 4, 230–238 (1967).
Tolman, R.L., Townsend, L.B., Robins, R.K.: Pyrrolopyrimidine nucleosides. III. The total synthesis of toyocamycin, sangivamycin, tubercidin, and related derivatives. J. Amer. Chem. Soc. 91, 2102–2108 (1969).
Tolman, R.L., Tolman, G.L., Robins, R.K., Townsend, L.B.: Pyrrolopyrimidine nucleosides. 6. Synthesis of 1, 3 and 7-β-D-ribofuranosylpyrrolo(2, 3-d)pyrimidines via silylated intermediates. J. Heterocycl. Chem. 7, 799–806 (1970).
Tong, G.L., Lee, W.W., Goodman, L.: Synthesis of some 3–0-methyl purine ribonucleosides. J. org. Chem. 32, 1984–1985 (1967a).
Tong, G.L., Ryan, K.J., Lee, W.W., Acton, E.M., Goodman, L.: Nucleosides of thioguanine and other 2-amino-6-substituted purines from 2-acetamido-6-chloropurine. J. org. Chem. 32, 859–862 (1967 b).
Tong, G.L., Lee, W.W., Goodman, L., Frederiksen, S.: Synthesis of some 2′-deoxyribosides of 8-azaadenine. Arch. Biochem. Biophys. 112, 76–81 (1965).
Traube, W.: Über 2-amino-adenin (2, 6-diaminopurin). Ber. 37, 4544–4547 (1904).
Vincze, A., Cohen, S.: Some N-substituted 6-methylpurines. Israel J. Chem. 4, 23–30 (1966).
Walton, E., Nutt, R.F., Jenkins, S.R., Holly, F.W.: 3′-Deoxynucleosides. I. A synthesis of 3′-deoxyadenosine. J. Amer. chem. Soc. 86, 2952 (1964).
Walton, E., Holly, F.W., Boxer, G.E., Nutt, R.F., Jenkins, S.R.: 3′-Deoxynucleosides. II. Purine 3′-deoxynucleosides. J. med. Chem. 8, 659–663 (1965).
Way, J. L., Parks, R.E.: Enzymatic synthesis of 5′-phosphate nucleotides of purine analogues. J. biol. Chem. 231, 467–480 (1958).
Wheeler, G.P., Alexander, J.A.: Searches for exploitable biochemical differences between normal and cancer cells. VIII. Catabolism of purines and purine nucleotides by sonicates. Cancer Res. 21, 407–421 (1961).
Wolfenden, R.: Enzymatic hydrolysis of 6-substituents on purine ribosides. J. Amer. chem. Soc. 88, 3157–3158 (1966).
Wolfrom, M.L., Thompson, A., Evans, E.F.: The action of diazomethane upon acyclic sugar derivatives. VII. D-Psicose. J. Amer. chem. Soc. 67, 1793–1797 (1945).
Woolley, D.W., Shaw, E.: Some imidazo-l,2,3-triazines and their biological relationship to the purines. J. biol. Chem. 189, 401–410 (1951).
Yamazaki, A., Kumashiro, L., Takenishi, T., Ikehara, M.: Synthesis of thio-AICA, 6-thio-xanthine, isoguanine analogs, and their ribosides. Chem. pharm. Bull. 16, 2172–2181 (1968).
York, J.L., LePage, G.A.: A kinetic study of the deamination of some adenosine analogues, substrate specificity of adenosine deaminase. Can. J. Biochem. 44, 331–337 (1966).
Yoshida, H., Duval, J., Ebel, J.P.: Halogenation of nucleic acids. VI. Iodination of nucleosides in dimethylformamide. Biochim. biophys. Acta (Amst.) 161, 13–22 (1968).
Yoshikawa, M. Kato, T., Takenishi, T.: A novel method for phosphorylation of nucleosides to 5′-nucleotides. Tetrahedron Let. 5065 (1967).
Yüntsen, H.: Chemical structure of angustmycin A. J. Antibiot. (Tokyo) 11, 233–243 (1958a).
Yüntsen, H.: Structure of angustmycin C. J. Antibiot. (Tokyo) 11, 244–249 (1958b).
Yüntsen, H., Yonehara, H., Ui, H.: A new antibiotic, angustmycin. I. J. Antibiot. (Japan) 7, 113–115 (1954).
Yüntsen, H., Ohkuma, K., Ishh, Y.: A new antibiotic, angustmycin. III. J. Antibiot. (Japan) 9, 195–201 (1956).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Montgomery, J.A. (1974). Rational Design of Purine Nucleoside Analogs. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents Part I. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65678-1_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-65678-1_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65680-4
Online ISBN: 978-3-642-65678-1
eBook Packages: Springer Book Archive